Concourse Financial Group Securities, Inc. Aditxt, Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
BUY
$0.13 - $0.46 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$0.34 - $0.58 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$0.54 - $2.51 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021
BUY
$1.54 - $3.04 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021
BUY
$2.2 - $3.2 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021
BUY
$2.08 - $5.26 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021
BUY
$1.89 - $2.48 $0 - $0
0 New
0 $0
Q3 2020

Nov 13, 2020
BUY
$1.7 - $7.6 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020
BUY
$5.06 - $5.06 $0 - $0
0 New
0 $0

About Aditxt, Inc.

ADTX Quotes by TradingView
  • Ticker ADTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,161,130
  • Market Cap $1.37M
  • Description
  • Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immuno...
More about ADTX
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email